3 he role of needle biopsy in the evaluation of unexplained pleural effusions is well established. [1] [2] [3] [4] The histologic demonstration of malignancy or granulomatous pleuritis is diagnostic, but the significance of a biopsy which reveals only nonspecific pleuritis is unclear. Carcinoma positive PPD, a pleural fluid lymphocytosis of greater than 95 percent, and an effusion which occupied more than half a hemithorax were significantly more common in the patients with malignant or granulomatous disease. Based on these results, a conservative approach is recommended for the patient with an initial biopsy which reveals only nonspecific pleuritis who has none of the criteria, but an aggressive diagnostic work-up in the individual with two or more criteria is advocated. (Chest 1988;  94:603-08)
The presenting symptoms, physical findings, results oflaboratory tests, and subsequent clinical course were ascertained from a review of the medical records. The initial and postbiopsy chest roentgenograms were reviewed by a single observer (GTK) without knowledge of the clinical history. Effusions visible on the lateral or decubitus but not on the PA chest x-ray film were classified as small, whereas those which occupied more than half a hemithorax were classified as large. Effusions between these two extremes were considered moderate. The presence of parenchymal abnormalities, masses, mediastinal shift toward the hemithorax with the effusion and adenopathy were considered to indicate an underlying "abnormal chest radiograph." Calcified granulomas or nodes, and mediastinal shift away from the involved hemithorax were noted but not considered significant roentgenographic abnormalities.
All biopsies were performed by a pulmonary attending or fellow under staff supervision. Three or four pieces of tissue were obtained with either a Cope or Abrams needle and submitted for histologic study and mycobacterial and fungal culture. Pleural fluid obtained at the time of the biopsy was routinely sent for a cell count with differential, protein, glucose, and LDH measurements, bacterial culture and cytologic examination. Additional specific tests, eg, an amylase level, were occasionally performed when clinically indicated.
Patients were classified into three groups according to their ultimate diagnosis. Patients were considered to have malignant pleural disease when malignant cells were observed on examination of the biopsy and/or pleural fluid specimens, or when there was documented carcinoma within the ipsilateral lung and no other identifiable cause for an exudative efusion. Those patients with granulomas on biopsy and/or positive cultures for mycobacteria or fungi were considered to have granulomatous pleuritis. The third group consisted of all those whose pleural biopsy revealed only mesothelial tissue with varying degrees of acute and chronic inflammation and who, upon follow-up, had no evidence of malignancy or granulomatous disease.
All data are presented as the mean (±+ SEM). The significance of the differences between the three groups was determined by analysis ofvariance, the chi square test, or Fisher's exact probability test where appropriate.9 Sensitivity and specificity were calculated according to standard formulas.'0
RESULTS
The 119 patients had a total of 177 closed pleural biopsies performed. All except two of the patients had a diagnostic thoracocentesis prior to the biopsy and the pleural fluid was exudative by standard criteria (pleural fluid to serum ratio for protein >0.5 and/or LDH ratio >0.6) in all but one of these patients. Forty-one of the 119 patients were ultimately diagnosed as having malignant effusions, while the diagnosis of granulomatous pleuritis was confirmed in 25 individuals. The diagnosis of malignant or granulomatous pleural disease was established in 63 (95 percent) of these 66 patients while they were in the hospital. Two patients with nonspecific pleuritis were clinically suspected of having a tuberculous effusion, but the diagnosis was not confirmed until six weeks after discharge when the pleural biopsy cultures grew Mycobacterium tuberculosis. One patient with malignancy was discharged after three nondiagnostic pleural biopsies; ten months later, a transbronchial biopsy established the diagnosis of metastatic adenocarcinoma.
The remaining patients were ultimately classified as having nonspecific pleuritis. The etiology of the effusions in these 53 individuals is presented in Table 1 . A single patient with lymphoma had nonspecific pleuritis on biopsy and nondiagnostic pleural fluid cytologic findings. He died of sepsis two months later, and unfortunately, permission for the autopsy was not granted. Although it is likely that the effusion was due to lymphoma, he is included in the idiopathic group since a malignant cause for the effusion could not be documented. None of the other patients with nonspecific pleuritis had evidence ofeither granulomatous infection or intrapleural malignancy during a follow-up period of 33 (±+ 3) months.
Congestive heart failure was the most frequently identified reason for the pleural effusion in patients with nonspecific pleuritis. Heart failure was clinically diagnosed in 13 individuals during their hospital stay, whereas it first became clinically overt after discharge in nine other patients. It may well be that the pleural effusion was unrelated to the development of heart failure in these latter individuals, and that their disease was idiopathic. In over one third of the patients, no potential cause for the effusion was ever apparent, and these were classified as idiopathic effusions. The first pleural biopsy was diagnostic ofmalignancy or granulomatous pleuritis in 32 (48 percent) of the 66 patients who were ultimately diagnosed to have either ofthese disorders. Eighty-seven patients had an initial pleural biopsy consistent with nonspecific pleuritis. Pleural tissue was identified in each of these biopsy specimens. Forty-five of the 87 patients underwent another closed pleural biopsy; 20 of these patients were ultimately diagnosed as having either malignant or granulomatous pleuritis, and this second procedure indicated a specific etiology in 11 (55 percent) of the 20 patients. In three of the 11 patients, the pleural biopsy was nondiagnostic, but the pleural fluid cytologic findings were positive. Two patients had pleural malignancy diagnosed by a third pleural biopsy, while one patient underwent four procedures before his diagnosis was confirmed. Overall morphologic evidence of malignancy or granulomas was demonstrated in 43 pleural biopsy specimens. The pleural biopsy was the only diagnostic specimen obtained in 22 patients with granulomatous pleuritis and 12 patients with malignant pleural disease. Six patients with nondiagnostic tissue specimens had either a positive tissue culture (n = 3) or pleural fluid cytologic findings (n = 3). In 17 patients, the malignant etiology of the pleural disease was established by the bronchoscopic demonstration of malignancy in the ipsilateral lung (n = 14) or by open biopsy (n = 3).
The clinical characteristics of the patients with malignant effusions, granulomatous pleuritis, and nonspecific pleuritis are presented in Table 2 . The age of the patients and proportion of women in each of the three groups was similar. The male preponderance is due to the fact that 72 of the 119 patients were from the VA Medical Center. Forty percent of the patients from LSU Medical Center were women. The patients with malignant pleural disease were symptomatic longer than the patients with granulomatous disease (p<0. 5). The duration of symptoms in the patients with nonspecific pleuritis was intermediate and not significantly different from either of the other two groups.
Pleuritic chest pain and other respiratory symptoms such as dyspnea and cough were common in all three groups. Weight loss exceeding 4.5 kg (10 lbs) was observed in a majority of the patients with granulomatous and malignant pleural disease and was the only symptom which was significantly more common than in patients with nonspecific pleuritis (p<O. 001). A majority of the patients with granulomatous pleuritis were febrile, a finding which was uncommon in the other two groups (p<0.001). Examination ofthe chest, heart, and abdomen revealed a similar frequency of abnormalities in each group. (p<0.001) in the patients with nonspecific pleuritis. The duration of the follow-up in the patients with malignant pleural disease, 5.3 (±+1.1) months, was significantly shorter than in the other two groups. The survival of the patients who required bronchoscopy or open biopsy to determine the etiology of their pleural disease, 5.2 (±+1.2) months, was virtually identical to that of the other patients with malignant pleural effusions. Forty of the 41 patients with malignant effusions died within 15 months of the recognition of their pleural disease. One patient with adenocarcinoma ofunknown origin had resolution ofher disease and is alive and without evidence of recurrence four years after the diagnosis. Although this patient clinically represents a false positive, she is included within the malignant group because her biopsy was reviewed and still considered diagnostic. All of the patients with granulomatous pleuritis responded to specific therapy.
The 53 patients with nonspecific pleuritis were followed for a mean of 33 (± 3) months. Forty-six (87 percent) of these 53 patients were no longer symptomatic and 34 (64 percent) had complete roentgenograhic resolution of their pleural disease. The other 12 asymptomatic patients still had residual pleural thickening and/or small effusions which were markedly improved when compared to their roent- The pleural disease has persisted unchanged in four additional individuals. One 80-year-old patient, who had an infiltrating ductal breast carcinoma resected, was being treated with tamoxifen when, four years after the initial surgery, she developed a pleural effusion in the ipsilateral hemithorax. Her pleural biopsy revealed only nonspecific pleuritis and the pleural fluid which had the characteristics of a transudate was attributed to congestive heart failure. The effusion has persisted unchanged for 44 months and several thoracocenteses subsequent to the initial biopsy have yielded cytologically-negative transudative pleural fluid. Persistent pleural disease of less than one years duration is thought to be due to chronic pancreatitis in one patient and chronic congestive heart failure in two other individuals.
The five clinical criteria which are listed in Table 3 were observed significantly more often in the patients who were diagnosed to have either granulomatous or malignant pleuritis. Individually, each criterion was a specific but not very sensitive indicator ofthe presence of either of these disorders. The sensitivity of these predictive indices was markedly improved by utilizing all the criteria as a group and considering the presence of any one to be a positive result (Fig 2) . Sixty-four (97 percent) of the 66 patients with granulomatous or malignant pleural disease had at least one of these criteria, and 44 (67 percent) of the 66 patients had two or more criteria. The specificity of these indicators of malignant or granulomatous pleuritis decreases when the presence of any criterion is considered positive since 22 (41 percent) ofthe 53 patients with nonspecific pleuritis also had at least one criterion present. However, only five (9 percent) of these 53 patients had two of the criteria. The positive predictive value of the criteria, ie, the probability of the patient having granulomatous or malignant pleural disease, was 74 percent when one criterion was present and increased to 90 percent if two criteria were present. When none of the criteria was present, the probability that the pleural disease represented nonspecific pleuritis was 94 percent. However, in contrast to many of these earlier reports, the patients in this study represented a highly selected population. Virtually all of the patients in the present study had a diagnostic thoracocentesis performed prior to the first pleural biopsy Pleural fluid from this initial thoracocentesis was generally submitted for both bacteriologic studies and cytologic examination. If the results of either of these tests had been positive, a pleural biopsy would not have been performed. Furthermore, many other patients with exudative effusions who were seen in consultation by the pulmonary service during the period of the study did not have a pleural biopsy because the etiology of their effusion was obvious, eg, a parapneumonic effusion in a patient with pneumonia. Thus, most of the patients in the present study truly had an unexplained pleural effusion after initial evaluation including a diagnostic thoracocentesis. However, since thoracocentesis is routinely performed by most physicians, the patients in the present study were probably representative of those who would be referred to a specialist for biopsy Needle biopsy of the pleura provided histologic evidence of malignancy or granulomas in 43 (65 percent) ofthe 66 patients with these diseases. The pleural fluid cytologic finding was positive in six (15 percent) of the 41 patients with malignancy, including three individuals who'had only nonspecific pleuritis on biopsy. The complementary role of performing both biopsy and cytology has been previously emphasized.51316
Although the yield of pleural fluid cytology has been reported to be higher in other series, these previous studies included the result of the initial pleural fluid cytology.6'7"1315-17 The fluid which was obtained at the time of pleural biopsy and submitted for cytologic study represented the second specimen in most patients. The frequency with which a positive result will be obtained decreases if the initial examination is negative.67"0 Ten (43 percent) of 23 patients with tuberculous pleuritis had positive tissue and/or pleural fluid cultures, and in three patients, this was the only proof of the cause of their effusion. Previous studies have also shown that simultaneous culture will increase the diagnostic yield in patients ultimately documented to have tuberculous pleuritis.45'8"1
Repeat pleural biopsy was a rewarding procedure in those patients who were ultimately diagnosed to have either malignant'or granulomatous pleuritis. The yield of the second pleural biopsy, 55 percent, was actually slightly higher than the 48 percent obtained on the first pleural biopsy. Pleural involvement in both these disorders usually is due to focal seeding with numerous malignant nodules or granulomas.'8", Therefore, it should not be surprising that a second biopsy performed at a different site would increase the frequency with which a diagnosis is obtained. Malignancy can also produce blockage of the mediastinal lymphatics and interfere with the reabsorption of pleural fluid, thereby causing the accumulation ofthe pleural fluid in the absence ofdirect pleural invasion. ' , This presumably was the reason for the effusions in the 14 patients with documented endobronchial cancer. Their rapidly progressive course, which was similar to that of the patients with documented pleural dissemination, argues against a coincidental nonmalignant etiology for their effusion and is consistent with the previously observed poor prognosis for patients with bronchogenic carcinoma and pleural disease.20 '22 In contrast to this dismal outcome in patients with malignant pleural disease, the majority of patients with nonspecific pleuritis had a good prognosis with resolution of their symptoms and clearing of their roentgenographic abnormalities. In a substantial number of patients, the effusion was ultimately attributed to congestive heart failure. In about one half of these individuals, the heart failure was recognized while they were in the hospital, but because of the atypical exudative nature of the effusion, pleural biopsy was performed. It is important to note that 24 of66 patients with cancer or granulomatous pleuritis also had clinical signs suggestive ofheart failure, so that the presence of cardiac disease does not exclude the possibility of a coexistent disorder. The congestive heart failure did not become clinically apparent in the remaining individuals with nonspecific pleuritis until after discharge, and it is uncertain if the exudative effusion was the result of transient cardiac decompensation or an unrelated disorder. In a substantial minority ofthe patients with nonspecific pleuritis, a reason for the effusion has never become apparent, and with the exception of the patient with lymphoma in whom a definite etiology could not be determined, all of these patients have done well. This is consistent with previous observations indicating that the prognosis of patients with unexplained pleural effusions is good.6 '23 It has been suggested previously that pleural biopsy will be a rewarding procedure in patients suspected, of having malignancy or granulomatous pleural disease. 1-557811-13,16 However, the reliability of clinical suspicion will vary depending on the expertise of the physician. To facilitate the recognition of patients in whom this procedure is likely to yield a specific diagnosis, we advocate combining all five objective criteria identified in this study into a single test which is positive when any criterion is present. When used in this manner, the criteria are extremely sensitive, as 97 percent of the patients with either cancer or granulomatous pleuritis had at least one criterion (Fig 2) .
The predictive value of the combined criteria was a modest 74 percent, however, since many of the patients with nonspecific pleuritis who underwent pleural biopsy also had at least one criterion. When two or more criteria were present, the positive predictive value was 90 percent, indicating a strong likelihood of obtaining a definitive diagnosis by biopsy. The real value of the criteria may lie in sparing patients with nonspecific pleuritis the morbidity and expense of a pleural biopsy since their negative predictive value was 94 percent, ie, the likelihood of diagnosing either malignancy or granulomatous pleuritis in the absence of any criterion was only 6 percent. Thirty-one of the 33 patients who did not have any criterion had a final diagnosis of nonspecific pleuritis (Fig 2) .
Based on our observations, we recommend the following diagnostic approach to the evaluation of an unexplained exudative pleural effusion. If the initial pleural biopsy reveals only nonspecific pleuritis in a patient without any of the five criteria, further pleural biopsies are not performed, and the patient is followed clinically. However, even when none of the criteria is present, bronchoscopy may be indicated if the patient has hemoptysis or if the chest roentgenogram reveals an undiagnosed parenchymal abnormality.24,; Pulmonary embolism is a common cause of exudative effusions that should be excluded by lung scanning before the diagnosis of idiopathic nonspecific pleuritis is accepted. In the presence of any one clinical criterion, a second pleural biopsy and/or bronchoscopy is performed. If both of these procedures fail to identify a specific etiology, the patient is followed clinically When two or more criteria are present, an aggressive diagnostic approach including repeat pleural biopsy, bronchoscopy, and if required, open pleural biopsy is recommended.
